feed,title,long_url,short_url
Benzinga,Investigator Says Apellis' Lead Product Shows 'First Direct Evidence Of Slowing Geographic Atrophy Lesion Growth',https://benzinga.com/general/biotech/22/10/29115675/apellis-lead-product-shows-first-direct-evidence-of-slowing-geographic-atrophy-lesion-growth,https://bit.ly/3UYnp5B
